FDAFDA recall D-0757-2026 · Aug 19, 2026
Apollo Care, LLC: SEMAGLUTIDE 20mg (5mg/mL) recall
Quick answer
- Product
- SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-724-04.
- Brand
- Apollo Care, LLC
- Codes, lots and dates
- Lot: AC-017275, Exp. 12/13/2026; AC-017282, AC-017285, Exp. 12/27/2026.
- Hazard
- Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
- Distribution
- Nationwide within the U.S
- Quantity
- 4,250 vials.
- Recall date
- Aug 19, 2026
- Agency
- U.S. Food and Drug Administration (FDA) enforcement report
- Recall number
- D-0757-2026
Recall found
Product
SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-724-04.
Reason for recall
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
What to do
FDA enforcement reports don't include consumer instructions. Check the codes below against your packaging. If this is a medicine or device you use, talk to your pharmacist or doctor before you stop or change anything, and contact the company or FDA for what to do with the product.
| Quantity | 4,250 vials. |
|---|---|
| Codes, lots and dates | Lot: AC-017275, Exp. 12/13/2026; AC-017282, AC-017285, Exp. 12/27/2026. |
| Distribution | Nationwide within the U.S |
| Recall date | Aug 19, 2026 |
| Class | Class II |
| Agency ID | D-0757-2026 |
| Official notice | U.S. Food and Drug Administration (FDA) enforcement report |
| Data as of, last checked | Nov 21, 2026, 3:48 PM EST |
Recall details
- FDA classification
- Class II: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
- Status
- Ongoing
- Codes, lots and dates
- Lot: AC-017275, Exp. 12/13/2026; AC-017282, AC-017285, Exp. 12/27/2026.
- Quantity
- 4,250 vials.
- Distribution
- Nationwide within the U.S
- Recalling firm
- Apollo Care, LLC, Columbia, MO
- Voluntary or mandated
- Voluntary: Firm initiated
- Recall started
- 2026-07-29
Source: openFDA enforcement record D-0757-2026 · search recall number D-0757-2026 in FDA's Enforcement Report.
Copied from the agency record without changes. Data as of Nov 21, 2026, 3:48 PM EST. The agency notice is the final word.
FAQ
What was recalled?
Product: SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-724-04. Brand: Apollo Care, LLC Codes, lots and dates: Lot: AC-017275, Exp. 12/13/2026; AC-017282, AC-017285, Exp. 12/27/2026.
What is the hazard?
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
How do I check if mine is affected?
Codes, lots and dates: Lot: AC-017275, Exp. 12/13/2026; AC-017282, AC-017285, Exp. 12/27/2026.
Where was it distributed?
Nationwide within the U.S
